Home » Authors » Mark McCarty

Articles by Mark McCarty

Report from Washington: China in trade talks agreeing to reduce med-tech barriers

April 14, 2006

By Mark McCarty

Washington roundup: Advanced imaging lauded as key to winning 'war on cancer'

April 13, 2006

By Mark McCarty

AHRQ review: efficacy studies and physician performance

April 11, 2006

By Mark McCarty

Washington roundup: Advanced imaging lauded as key to winning 'war on cancer'

April 7, 2006

By Mark McCarty

OTC sales for fetal heartbeat ultrasound intensely debated

April 6, 2006

By Mark McCarty

Firms signing up for voluntary ethics code as investigations roll

April 5, 2006

By Mark McCarty

Partners break into market with pneumatic VAD pump

April 3, 2006

By Mark McCarty

OTC sales for fetal heartbeat ultrasound intensely debated

March 31, 2006

By Mark McCarty

Devices seemingly peripheral in FDA's critical path blueprint

March 30, 2006

By Mark McCarty

Cambridge Heart wins new CMS reimbursement for HearTwave

March 30, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 21, 2025.
Makary’s vision for slimmed-down US FDA somewhat reassuring
BioWorld
Nearly three weeks into the job, U.S. FDA Commissioner Marty Makary provided a comprehensive overview of his vision for the much-reduced agency, even as he’s...
Ouch! Tariffs hit med tech harder than expected
BioWorld MedTech
First quarter earnings reports from Johnson & Johnson and Abbott Laboratories provided some surprising insights into the likely hit med-tech companies will...
Dupixent bounces back in treating hives with FDA approval
BioWorld
The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for...